Daiichi Sankyo Co Ltd Sponsored ADR Level 1


By |


Daiichi Sankyo Co Ltd is a Japanese pharmaceutical company. It focuses on research and development for bringing up forth novel therapies in oncology, including immune oncology, with further focus on new areas, such as pain management, neurodegenerative diseases, heart and kidney diseases. Daiichi, through pharmaceutical technology platform, develops processes for manufacturing of quality pharmaceuticals that meet desired efficacy and safety parameters. Daiichi is involved in process technology, biotechnology, formulation technology, analytical and quality evaluation technology. Its products brand includes PRALIA, MOVANTIK, LIXIANA, levofloxacin, Injectafer and others. The company has its business operations in Europe, North America, and Japan. Most of its revenue comes from Japan.

Contact Information

Website: www.daiichisankyo.co.jp
Main Phone: +81 362251111
Address: 3-5-1, Nihonbashi-honcho
Address 2: Chuo-ku
City / Town: Tokyo
Country: JPN
Postal Code: 103-8426

Issuer Information

Exchange: OTO
Employees: 14446
$ 35.50 $ -1.405 (-3.81%)
Last Price 35.50 Change $ -1.405 Change % -3.81 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 35.48 High 35.74 Low 35.29 Prev Close 36.91
Last Trade Volume 35,742 52 Wk Hi 43.74 52 Wk Low 24.37
Market Cap 23 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 647,667,596.00 EPS (TTM) 0.80 PE Ratio 48.30 Exchange OTCPK